U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Acute disseminated encephalomyelitis with anti-MOG antibodies

MedGen UID:
1842363
•Concept ID:
C5680301
•
Disease or Syndrome
Synonyms: acute disseminated encephalomyelitis with anti-MOG antibodies; Acute disseminated encephalomyelitis with anti-myelin oligodendrocyte glycoprotein antibodies; ADEM with anti-MOG antibodies
 
Monarch Initiative: MONDO:0035669
Orphanet: ORPHA592894

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVAcute disseminated encephalomyelitis with anti-MOG antibodies

Professional guidelines

PubMed

Pathogenesis, Clinical Features, and Treatment of Patients with Myelin Oligodendrocyte Glycoprotein (MOG) Autoantibody-Associated Disorders Focusing on Optic Neuritis with Consideration of Autoantibody-Binding Sites: A Review.
Tanaka K, Kezuka T, Ishikawa H, Tanaka M, Sakimura K, Abe M, Kawamura M
Int J Mol Sci 2023 Aug 29;24(17) doi: 10.3390/ijms241713368. PMID: 37686172Free PMC Article
Paediatric acute disseminated encephalomyelitis followed by optic neuritis: disease course, treatment response and outcome.
Wong YYM, Hacohen Y, Armangue T, Wassmer E, Verhelst H, Hemingway C, van Pelt ED, Catsman-Berrevoets CE, Hintzen RQ, Deiva K, Lim MJ, Rostásy K, Neuteboom RF
Eur J Neurol 2018 May;25(5):782-786. Epub 2018 Mar 9 doi: 10.1111/ene.13602. PMID: 29443442

Recent clinical studies

Etiology

Clinical outcomes and Anti-MOG antibodies in pediatric optic neuritis: A prospective observational study.
Nair A, Sankhyan N, Sukhija J, Saini AG, Vyas S, Suthar R, Sahu JK, Rawat A
Eur J Paediatr Neurol 2024 Mar;49:1-5. Epub 2024 Jan 17 doi: 10.1016/j.ejpn.2024.01.003. PMID: 38271780
Myelin Oligodendrocyte Glycoprotein-Associated Disorders.
Longbrake E
Continuum (Minneap Minn) 2022 Aug 1;28(4):1171-1193. doi: 10.1212/CON.0000000000001127. PMID: 35938661Free PMC Article
Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience.
Rempe T, Tarhan B, Rodriguez E, Viswanathan VT, Gyang TV, Carlson A, Tuna IS, Rees J
Mult Scler Relat Disord 2021 Feb;48:102718. Epub 2020 Dec 24 doi: 10.1016/j.msard.2020.102718. PMID: 33388560
Paediatric acute disseminated encephalomyelitis followed by optic neuritis: disease course, treatment response and outcome.
Wong YYM, Hacohen Y, Armangue T, Wassmer E, Verhelst H, Hemingway C, van Pelt ED, Catsman-Berrevoets CE, Hintzen RQ, Deiva K, Lim MJ, Rostásy K, Neuteboom RF
Eur J Neurol 2018 May;25(5):782-786. Epub 2018 Mar 9 doi: 10.1111/ene.13602. PMID: 29443442
Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort.
Ketelslegers IA, Van Pelt DE, Bryde S, Neuteboom RF, Catsman-Berrevoets CE, Hamann D, Hintzen RQ
Mult Scler 2015 Oct;21(12):1513-20. Epub 2015 Feb 6 doi: 10.1177/1352458514566666. PMID: 25662345

Diagnosis

Pathogenesis, Clinical Features, and Treatment of Patients with Myelin Oligodendrocyte Glycoprotein (MOG) Autoantibody-Associated Disorders Focusing on Optic Neuritis with Consideration of Autoantibody-Binding Sites: A Review.
Tanaka K, Kezuka T, Ishikawa H, Tanaka M, Sakimura K, Abe M, Kawamura M
Int J Mol Sci 2023 Aug 29;24(17) doi: 10.3390/ijms241713368. PMID: 37686172Free PMC Article
Myelin Oligodendrocyte Glycoprotein-Associated Disorders.
Longbrake E
Continuum (Minneap Minn) 2022 Aug 1;28(4):1171-1193. doi: 10.1212/CON.0000000000001127. PMID: 35938661Free PMC Article
Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience.
Rempe T, Tarhan B, Rodriguez E, Viswanathan VT, Gyang TV, Carlson A, Tuna IS, Rees J
Mult Scler Relat Disord 2021 Feb;48:102718. Epub 2020 Dec 24 doi: 10.1016/j.msard.2020.102718. PMID: 33388560
MOG antibody-associated encephalomyelitis/encephalitis.
Salama S, Khan M, Pardo S, Izbudak I, Levy M
Mult Scler 2019 Oct;25(11):1427-1433. Epub 2019 Mar 25 doi: 10.1177/1352458519837705. PMID: 30907249Free PMC Article
Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination.
Ramanathan S, Dale RC, Brilot F
Autoimmun Rev 2016 Apr;15(4):307-24. Epub 2015 Dec 17 doi: 10.1016/j.autrev.2015.12.004. PMID: 26708342

Therapy

Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19: Systematic Review and Meta-synthesis.
Manzano GS, McEntire CRS, Martinez-Lage M, Mateen FJ, Hutto SK
Neurol Neuroimmunol Neuroinflamm 2021 Nov;8(6) Epub 2021 Aug 27 doi: 10.1212/NXI.0000000000001080. PMID: 34452974Free PMC Article
Acute Disseminated Encephalomyelitis (ADEM) and Increased Intracranial Pressure Associated With Anti-Myelin Oligodendrocyte Glycoprotein Antibodies.
Narayan RN, Wang C, Greenberg BM
Pediatr Neurol 2019 Oct;99:64-68. Epub 2019 Mar 22 doi: 10.1016/j.pediatrneurol.2019.03.009. PMID: 31248672
MOG antibody-associated encephalomyelitis/encephalitis.
Salama S, Khan M, Pardo S, Izbudak I, Levy M
Mult Scler 2019 Oct;25(11):1427-1433. Epub 2019 Mar 25 doi: 10.1177/1352458519837705. PMID: 30907249Free PMC Article
Inflammatory demyelinating diseases of the central nervous system in Niger.
Assadeck H, Toudou Daouda M, Adehossi Omar É, Mamadou Z, Hassane Djibo F, Douma Maiga D
Rev Neurol (Paris) 2019 Apr;175(4):261-268. Epub 2018 Sep 27 doi: 10.1016/j.neurol.2018.05.003. PMID: 30270137
Paediatric acute disseminated encephalomyelitis followed by optic neuritis: disease course, treatment response and outcome.
Wong YYM, Hacohen Y, Armangue T, Wassmer E, Verhelst H, Hemingway C, van Pelt ED, Catsman-Berrevoets CE, Hintzen RQ, Deiva K, Lim MJ, Rostásy K, Neuteboom RF
Eur J Neurol 2018 May;25(5):782-786. Epub 2018 Mar 9 doi: 10.1111/ene.13602. PMID: 29443442

Prognosis

Myelin Oligodendrocyte Glycoprotein-Associated Disorders.
Longbrake E
Continuum (Minneap Minn) 2022 Aug 1;28(4):1171-1193. doi: 10.1212/CON.0000000000001127. PMID: 35938661Free PMC Article
Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience.
Rempe T, Tarhan B, Rodriguez E, Viswanathan VT, Gyang TV, Carlson A, Tuna IS, Rees J
Mult Scler Relat Disord 2021 Feb;48:102718. Epub 2020 Dec 24 doi: 10.1016/j.msard.2020.102718. PMID: 33388560
Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in patients with optic neuritis and seizures.
Gutman JM, Kupersmith M, Galetta S, Kister I
J Neurol Sci 2018 Apr 15;387:170-173. Epub 2018 Feb 2 doi: 10.1016/j.jns.2018.01.042. PMID: 29571858
Paediatric acute disseminated encephalomyelitis followed by optic neuritis: disease course, treatment response and outcome.
Wong YYM, Hacohen Y, Armangue T, Wassmer E, Verhelst H, Hemingway C, van Pelt ED, Catsman-Berrevoets CE, Hintzen RQ, Deiva K, Lim MJ, Rostásy K, Neuteboom RF
Eur J Neurol 2018 May;25(5):782-786. Epub 2018 Mar 9 doi: 10.1111/ene.13602. PMID: 29443442
Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination.
Ramanathan S, Dale RC, Brilot F
Autoimmun Rev 2016 Apr;15(4):307-24. Epub 2015 Dec 17 doi: 10.1016/j.autrev.2015.12.004. PMID: 26708342

Clinical prediction guides

Life-Threatening MOG Antibody-Associated Hemorrhagic ADEM With Elevated CSF IL-6.
Virupakshaiah A, Moseley CE, Elicegui S, Gerwitz LM, Spencer CM, George E, Shah M, Cree BAC, Waubant E, Zamvil SS
Neurol Neuroimmunol Neuroinflamm 2024 Jul;11(4):e200243. Epub 2024 Apr 17 doi: 10.1212/NXI.0000000000200243. PMID: 38630950Free PMC Article
Clinical outcomes and Anti-MOG antibodies in pediatric optic neuritis: A prospective observational study.
Nair A, Sankhyan N, Sukhija J, Saini AG, Vyas S, Suthar R, Sahu JK, Rawat A
Eur J Paediatr Neurol 2024 Mar;49:1-5. Epub 2024 Jan 17 doi: 10.1016/j.ejpn.2024.01.003. PMID: 38271780
Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19: Systematic Review and Meta-synthesis.
Manzano GS, McEntire CRS, Martinez-Lage M, Mateen FJ, Hutto SK
Neurol Neuroimmunol Neuroinflamm 2021 Nov;8(6) Epub 2021 Aug 27 doi: 10.1212/NXI.0000000000001080. PMID: 34452974Free PMC Article
Serial Anti-Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes.
Waters P, Fadda G, Woodhall M, O'Mahony J, Brown RA, Castro DA, Longoni G, Irani SR, Sun B, Yeh EA, Marrie RA, Arnold DL, Banwell B, Bar-Or A; Canadian Pediatric Demyelinating Disease Network
JAMA Neurol 2020 Jan 1;77(1):82-93. doi: 10.1001/jamaneurol.2019.2940. PMID: 31545352Free PMC Article
Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort.
Ketelslegers IA, Van Pelt DE, Bryde S, Neuteboom RF, Catsman-Berrevoets CE, Hamann D, Hintzen RQ
Mult Scler 2015 Oct;21(12):1513-20. Epub 2015 Feb 6 doi: 10.1177/1352458514566666. PMID: 25662345

Recent systematic reviews

Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19: Systematic Review and Meta-synthesis.
Manzano GS, McEntire CRS, Martinez-Lage M, Mateen FJ, Hutto SK
Neurol Neuroimmunol Neuroinflamm 2021 Nov;8(6) Epub 2021 Aug 27 doi: 10.1212/NXI.0000000000001080. PMID: 34452974Free PMC Article
Aseptic meningitis and leptomeningeal enhancement associated with anti-MOG antibodies: A review.
Gombolay GY, Gadde JA
J Neuroimmunol 2021 Sep 15;358:577653. Epub 2021 Jul 1 doi: 10.1016/j.jneuroim.2021.577653. PMID: 34229204

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Reviews

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...